Central Nervous System News and Research

RSS

Is COVID-19 a risk factor for Alzheimer's disease?

The study explores the interconnected risks between COVID-19 and Alzheimer's Disease (AD), highlighting how SARS-CoV-2 can aggravate AD pathology through neuroinflammation and neurodegeneration. It raises significant concerns about the long-term cognitive implications of COVID-19, especially among those already at risk for AD.

23 Oct 2023

Sugar-sweetened beverages pose a potential risk of ADHD

The consumption of sugar-sweetened beverages was associated with ADHD.

19 Oct 2023

How the gut microbiome contributes to schizophrenia

Researchers explore potential relationships between schizophrenia, the gut microbiome, the gut-brain axis, and short-chain fatty acids.

19 Oct 2023

How do different organ microbiomes influence neuropsychiatric disorders?

Scientists review existing literature to understand how the microbiome influences neuropsychiatric disorders.

19 Oct 2023

Turning brain immune cells into neurons restores brain function after stroke-like injury in mice

Researchers at Kyushu University have discovered that turning brain immune cells into neurons successfully restores brain function after stroke-like injury in mice.

18 Oct 2023

FAST joins with University of Pennsylvania to develop investigational AAV gene therapy for Angelman syndrome

The Foundation for Angelman Syndrome Therapeutics (FAST) announced today that the non-profit organization has entered into an exclusive global collaborative research and development agreement with the University of Pennsylvania to develop an investigational adeno-associated virus (AAV) gene therapy for Angelman syndrome (AS).

17 Oct 2023

SwRI develops unique technology for safe and efficient synthesis of OPNA oxime antidotes

Southwest Research Institute has developed a unique technology (US20230242487A1) that enables the safe and efficient synthesis of organophosphorus nerve agent (OPNA) oxime antidotes.

17 Oct 2023

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Clinical stage artificial intelligence (AI) drug discovery company Insilico Medicine ("Insilico") has been invited to present scientific data on its novel anti-cancer assets at three major upcoming cancer conferences -- the European Society for Medical Oncology (ESMO) conference in Madrid Oct. 20-24, 2023; the Society of Immunotherapy of Cancer (SITC) conference Nov. 1-5, 2023 in San Diego; and the San Antonio Breast Cancer Symposium (SABCS) Dec. 5-9, 2023.

16 Oct 2023

Researchers identify new biomarker to predict neuronal regeneration after injury

Neurons, the main cells that make up our brain and spinal cord, are among the slowest cells to regenerate after an injury, and many neurons fail to regenerate entirely.

16 Oct 2023

AI innovation "Sturgeon" transforms classification of central nervous system malignancies

Sturgeon, a patient-agnostic transfer-learned neural network, to enable molecular subclassification of CNS malignancies.

16 Oct 2023

Are migraines linked to gut health and chronic non-communicable diseases?

The Links Between Migraines, Gut Health, and Chronic Non-Communicable Diseases (CNCDs).

13 Oct 2023

Ketogenic diets found to slash migraine frequency and fatigue in new study

Italian researchers find that ketogenic diets not only reduce the frequency and intensity of migraines but also significantly alleviate fatigue in sufferers. The study opens new doors for alternative, diet-based therapies for chronic and high-frequency episodic migraineurs.

12 Oct 2023

Intracellular journey: The penetration of antidepressants into cells, organelles, and membranes

Researchers in neuropsychopharmacology challenge conventional wisdom about antidepressants' actions, revealing significant intracellular activity that influences their effectiveness. Utilizing advanced technologies, the study prompts a reevaluation of drug targeting and mechanisms, opening new avenues for treating depression.

12 Oct 2023

Could young blood be the key to reversing age-related cognitive decline?

Researchers at the University of Auckland identify platelet factor 4 (PF4) in young blood as a key player in reversing age-related cognitive decline in mice. The study offers a promising avenue for treating dementia-related conditions and enhancing brain function in aging populations.

11 Oct 2023

Central Nervous System News and Research

Is COVID-19 a risk factor for Alzheimer's disease?

Sugar-sweetened beverages pose a potential risk of ADHD

How the gut microbiome contributes to schizophrenia

How do different organ microbiomes influence neuropsychiatric disorders?

Turning brain immune cells into neurons restores brain function after stroke-like injury in mice

FAST joins with University of Pennsylvania to develop investigational AAV gene therapy for Angelman syndrome

SwRI develops unique technology for safe and efficient synthesis of OPNA oxime antidotes

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Researchers identify new biomarker to predict neuronal regeneration after injury

AI innovation "Sturgeon" transforms classification of central nervous system malignancies

Are migraines linked to gut health and chronic non-communicable diseases?

Ketogenic diets found to slash migraine frequency and fatigue in new study

Intracellular journey: The penetration of antidepressants into cells, organelles, and membranes

Could young blood be the key to reversing age-related cognitive decline?

Unveiling the role of astrocyte-derived LCN2 in neurodegenerative disease progression

Study identifies potential drug target for lymphedema

New protein identified as substrate for histidine methylation

Advancement of potential gene therapy could offer new hope for children with Batten disease

Discovery sheds new light on the chain of events in early embryonic development

How do micronutrients influence neurological disorders?

Event guide: The 7th CNS Drug Delivery Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News